Shire Pharmaceuticals Inc., a global specialty-biopharmaceuticals company, plans to create 390 new jobs within four years as part of its $30 million headquarters expansion project in Chester County, Pa.

Shire is leasing a 115,000 square foot building near its U.S. headquarters in the Chesterbrook Corporate Center in Wayne, Pa. The company is renovating the 1200 Morris Drive facility, which has been vacant for more than five years, and acquiring furniture, fixtures and equipment while striving to make the building as “green” as possible.

“As Shire Pharmaceuticals continues to grow, there is no better place for us to call home than Pennsylvania,” said Matthew Emmens, Shire’s chief executive officer. “The productive talent pool, the quality of life and the support for business in the commonwealth are second to none. We’re proud to be a part of this region’s growing biopharmaceutical and technology corridor.”

Shire worked with the Governor’s Action Team to secure a $2.07 million funding offer from DCED, including a $600,000 Opportunity Grant, $300,000 in Customized Job Training assistance and $1.17 million in Job Creation Tax Credits. The company is also eligible to apply for Pennsylvania R&D Tax Credits as its new operation will include significant research functions.

For MORE NEWS BRIEFS, click here.

For a FREE SUBSCRIPTION to Expansion Management magazine, click here.

For MORE NEWS BRIEFS SORTED BY STATE, click here.

For MORE NEWS BRIEFS SORTED BY INDUSTRY or FUNCTION, click here.

For MORE NEWS BRIEFS SORTED BY COUNTRY, click here.